iRadimed IRMD Return on equity
Return on equity at other companies
Other financials
Where this comes from
Calculated from iRadimed’s reported figures.
Based on trailing twelve months.
The official record: iRadimed’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →
Ask your AI about iRadimed's return on equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is iRadimed's return on equity?
- iRadimed (IRMD) reported return on equity of 25% in Q1 2026.
- How has iRadimed's return on equity changed year-over-year?
- iRadimed's return on equity increased by 5.2% year-over-year, from 23.8% to 25%.
- What is the long-term trend for iRadimed's return on equity?
- Over 5 years (2020 to 2025), iRadimed's return on equity has grown at a 60.3% compound annual growth rate (CAGR), from 2.3% to 24.8%.
- What does return on equity mean?
- Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.